A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors
Clinical trial NCT03195478 · COMPLETED
Trial details
- NCT number
- NCT03195478
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2024-01-05
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.